IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $107,985 | -48.6% | 6,962 | -41.2% | 0.07% | -53.1% |
Q4 2022 | $210,270 | +61.7% | 11,846 | -49.0% | 0.15% | +58.1% |
Q3 2022 | $130,000 | +47.7% | 23,245 | +3.4% | 0.09% | +47.6% |
Q2 2022 | $88,000 | +18.9% | 22,482 | +66.9% | 0.06% | +34.0% |
Q1 2022 | $74,000 | -20.4% | 13,469 | +23.8% | 0.05% | -14.5% |
Q4 2021 | $93,000 | -5.1% | 10,879 | -3.9% | 0.06% | -12.7% |
Q3 2021 | $98,000 | – | 11,319 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |